Cargando…

Cell Origins of High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jaeyeon, Park, Eun Young, Kim, Olga, Schilder, Jeanne M., Coffey, Donna M., Cho, Chi-Heum, Bast, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267333/
https://www.ncbi.nlm.nih.gov/pubmed/30424539
http://dx.doi.org/10.3390/cancers10110433
_version_ 1783376043475730432
author Kim, Jaeyeon
Park, Eun Young
Kim, Olga
Schilder, Jeanne M.
Coffey, Donna M.
Cho, Chi-Heum
Bast, Robert C.
author_facet Kim, Jaeyeon
Park, Eun Young
Kim, Olga
Schilder, Jeanne M.
Coffey, Donna M.
Cho, Chi-Heum
Bast, Robert C.
author_sort Kim, Jaeyeon
collection PubMed
description High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear where HGSC truly originates. Traditionally, the ovarian surface epithelium (OSE) was long believed to be the origin of HGSC. Since the late 1990s, the fallopian tube epithelium has emerged as a potential primary origin of HGSC. Particularly, serous tubal intraepithelial carcinoma (STIC), a noninvasive tumor lesion formed preferentially in the distal fallopian tube epithelium, was proposed as a precursor for HGSC. It was hypothesized that STIC lesions would progress, over time, to malignant and metastatic HGSC, arising from the fallopian tube or after implanting on the ovary or peritoneum. Many clinical studies and several mouse models support the fallopian tube STIC origin of HGSC. Current evidence indicates that STIC may serve as a precursor for HGSC in high-risk women carrying germline BRCA1 or 2 mutations. Yet not all STIC lesions appear to progress to clinical HGSCs, nor would all HGSCs arise from STIC lesions, even in high-risk women. Moreover, the clinical importance of STIC remains less clear in women in the general population, in which 85–90% of all HGSCs arise. Recently, increasing attention has been brought to the possibility that many potential precursor or premalignant lesions, though composed of microscopically—and genetically—cancerous cells, do not advance to malignant tumors or lethal malignancies. Hence, rigorous causal evidence would be crucial to establish that STIC is a bona fide premalignant lesion for metastatic HGSC. While not all STICs may transform into malignant tumors, these lesions are clearly associated with increased risk for HGSC. Identification of the molecular characteristics of STICs that predict their malignant potential and clinical behavior would bolster the clinical importance of STIC. Also, as STIC lesions alone cannot account for all HGSCs, other potential cellular origins of HGSC need to be investigated. The fallopian tube stroma in mice, for instance, has been shown to be capable of giving rise to metastatic HGSC, which faithfully recapitulates the clinical behavior and molecular aspect of human HGSC. Elucidating the precise cell(s) of origin of HGSC will be critical for improving the early detection and prevention of ovarian cancer, ultimately reducing ovarian cancer mortality.
format Online
Article
Text
id pubmed-6267333
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62673332018-12-03 Cell Origins of High-Grade Serous Ovarian Cancer Kim, Jaeyeon Park, Eun Young Kim, Olga Schilder, Jeanne M. Coffey, Donna M. Cho, Chi-Heum Bast, Robert C. Cancers (Basel) Review High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear where HGSC truly originates. Traditionally, the ovarian surface epithelium (OSE) was long believed to be the origin of HGSC. Since the late 1990s, the fallopian tube epithelium has emerged as a potential primary origin of HGSC. Particularly, serous tubal intraepithelial carcinoma (STIC), a noninvasive tumor lesion formed preferentially in the distal fallopian tube epithelium, was proposed as a precursor for HGSC. It was hypothesized that STIC lesions would progress, over time, to malignant and metastatic HGSC, arising from the fallopian tube or after implanting on the ovary or peritoneum. Many clinical studies and several mouse models support the fallopian tube STIC origin of HGSC. Current evidence indicates that STIC may serve as a precursor for HGSC in high-risk women carrying germline BRCA1 or 2 mutations. Yet not all STIC lesions appear to progress to clinical HGSCs, nor would all HGSCs arise from STIC lesions, even in high-risk women. Moreover, the clinical importance of STIC remains less clear in women in the general population, in which 85–90% of all HGSCs arise. Recently, increasing attention has been brought to the possibility that many potential precursor or premalignant lesions, though composed of microscopically—and genetically—cancerous cells, do not advance to malignant tumors or lethal malignancies. Hence, rigorous causal evidence would be crucial to establish that STIC is a bona fide premalignant lesion for metastatic HGSC. While not all STICs may transform into malignant tumors, these lesions are clearly associated with increased risk for HGSC. Identification of the molecular characteristics of STICs that predict their malignant potential and clinical behavior would bolster the clinical importance of STIC. Also, as STIC lesions alone cannot account for all HGSCs, other potential cellular origins of HGSC need to be investigated. The fallopian tube stroma in mice, for instance, has been shown to be capable of giving rise to metastatic HGSC, which faithfully recapitulates the clinical behavior and molecular aspect of human HGSC. Elucidating the precise cell(s) of origin of HGSC will be critical for improving the early detection and prevention of ovarian cancer, ultimately reducing ovarian cancer mortality. MDPI 2018-11-12 /pmc/articles/PMC6267333/ /pubmed/30424539 http://dx.doi.org/10.3390/cancers10110433 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Jaeyeon
Park, Eun Young
Kim, Olga
Schilder, Jeanne M.
Coffey, Donna M.
Cho, Chi-Heum
Bast, Robert C.
Cell Origins of High-Grade Serous Ovarian Cancer
title Cell Origins of High-Grade Serous Ovarian Cancer
title_full Cell Origins of High-Grade Serous Ovarian Cancer
title_fullStr Cell Origins of High-Grade Serous Ovarian Cancer
title_full_unstemmed Cell Origins of High-Grade Serous Ovarian Cancer
title_short Cell Origins of High-Grade Serous Ovarian Cancer
title_sort cell origins of high-grade serous ovarian cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267333/
https://www.ncbi.nlm.nih.gov/pubmed/30424539
http://dx.doi.org/10.3390/cancers10110433
work_keys_str_mv AT kimjaeyeon celloriginsofhighgradeserousovariancancer
AT parkeunyoung celloriginsofhighgradeserousovariancancer
AT kimolga celloriginsofhighgradeserousovariancancer
AT schilderjeannem celloriginsofhighgradeserousovariancancer
AT coffeydonnam celloriginsofhighgradeserousovariancancer
AT chochiheum celloriginsofhighgradeserousovariancancer
AT bastrobertc celloriginsofhighgradeserousovariancancer